| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/11/2009 | US7572886 Death associated proteins, and THAP1 and PAR4 pathways in apoptosis control |
| 08/11/2009 | US7572883 Somatostatin-dopamine chimeric analogs |
| 08/11/2009 | US7572833 E.g., N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal stabilized with a lipid; improved absorption and penetration; treating ischemia, immune diseases, Alzheimer's disease, osteoporosis, brain disorders, eye diseases, osteoporosis |
| 08/11/2009 | US7572817 Carboxypeptidase U inhibitors; thrombosis, atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases; e.g. 2-[(6-Aminopyridin-3-yl)methyl]-3-mercapto-5-[3-(pyrrolidin-1-ylcarbonyl)phenyl]pentanoic acid |
| 08/11/2009 | US7572813 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; N-[2-[[(cis) -2-[[1- (4-Chlorophenyl)ethyl]amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide |
| 08/11/2009 | US7572801 Pyridopyrimidinone derivatives which are HM74A agonists |
| 08/11/2009 | US7572799 Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors |
| 08/11/2009 | US7572796 excitatory amino acid antagonists for treating neurodegenerative diseases as cerebrovascular diseases, epilepsy, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, cerebral ischaemia, infarction, psychoses; 6-{3-[4-(4-fluorobenzyl)-1-piperidyl]propyl}-1H-indole-3-carbonitrile |
| 08/11/2009 | US7572795 Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors |
| 08/11/2009 | US7572791 Long-term stability, extended delivery using a suitable reservoir; pumped or metered at a controlled rate; implantable or external pump device, pen style injection device; stable at physiologic temperatures for duration of therapeutic exposure; supply of therapeutically active material for up to 2 years |
| 08/11/2009 | US7572779 Improved oral bioavailability of 17 beta-estradiol by adminstering the lower alkanoate; contraceptives, hormone replacement therapy |
| 08/11/2009 | US7572774 Methods for treating glutamate cytotoxicity with beta-naphthoquinone compounds |
| 08/11/2009 | US7572762 Materials and methods relating to the induction of apoptosis in target cells |
| 08/11/2009 | US7572605 1,2,3,tris(4-hydroxy-butyroyloxy)propane; enhance the uptake of the drug, deliver effective therapeutic doses in a time-delayed fashion, and target specific organs |
| 08/11/2009 | US7572470 Licorice extract for use as a medicament |
| 08/11/2009 | US7572467 Compositions comprising organic extracts of Geum japonicum thunb var. and the use thereof |
| 08/11/2009 | US7572463 Oral dosage forms |
| 08/11/2009 | US7572442 Selected antibody compositions for binding to aminophospholipids |
| 08/11/2009 | CA2482551C 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists |
| 08/11/2009 | CA2449402C Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 08/11/2009 | CA2448825C Pharmaceutical compositions of adsorbates of amorphous drug |
| 08/11/2009 | CA2408535C Compositions comprising dendrimer complexes |
| 08/11/2009 | CA2395846C Diazepan derivatives or salts thereof |
| 08/11/2009 | CA2382013C Pharmaceutical solutions of levosimendan |
| 08/11/2009 | CA2368688C Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 08/11/2009 | CA2367410C Novel process for the preparation of 1-phenyl-2-(2-piridyl)ethanamine |
| 08/11/2009 | CA2359772C Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 08/11/2009 | CA2331393C Fatty acid analogues for the treatment of primary and secondary restenosis |
| 08/06/2009 | WO2009097416A1 Imidazolylalkyl- pyridines as dbh inhibitors |
| 08/06/2009 | WO2009096503A1 Benzyl phenyl glucopyranoside derivative |
| 08/06/2009 | WO2009096425A1 Neovascularization-promoting factor |
| 08/06/2009 | WO2009095499A1 Use of amidoxime carboxylic acid esters and n-hydroxyguanidine carboxylic acid esters for producing prodrugs |
| 08/06/2009 | WO2009095394A1 Diazepanes as histamine h3 receptor antagonists |
| 08/06/2009 | WO2009095265A1 The use of substances for the treatment of central or peripheral insulin receptor impairment and insulin resistance |
| 08/06/2009 | WO2009095163A2 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 08/06/2009 | WO2009095162A1 Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 08/06/2009 | WO2009094811A1 A royal jelly acidic mixture preparation and application thereof |
| 08/06/2009 | WO2009094718A1 Methods of treating thromboembolic disorders |
| 08/06/2009 | WO2009049914A3 Novel patient subgroups for thrombolysis |
| 08/06/2009 | WO2009047791A3 Toll like receptor (tlr) signaling antagonist |
| 08/06/2009 | WO2009043522A3 Use of a peptide as a therapeutic agent |
| 08/06/2009 | WO2009043463A3 Use of gluten exorphin c : as a therapeutic agent |
| 08/06/2009 | WO2009040086A3 Use of salusin-alpha as a therapeutic agent |
| 08/06/2009 | WO2009036149A3 Methods for treatment of degenerative disease associated with apoptosis |
| 08/06/2009 | WO2009033795A3 Use of a obestatin as a therapeutic agent |
| 08/06/2009 | WO2009033793A3 Pentagastrin as a therapeutic agent |
| 08/06/2009 | WO2009033721A3 Use of salusin beta alone or in combination with octreotide as a therapeutic agent |
| 08/06/2009 | WO2009004152A3 Use of a composition of oligomers of galacturonic acid as an agent for inhibiting degradation of collagen |
| 08/06/2009 | WO2002074782A3 Isolation and purification procedure of vasopeptidase peptide inhibitors |
| 08/06/2009 | US20090197966 Use of Hypothermia Inducing Drugs |
| 08/06/2009 | US20090197945 Method for Generating Reference Controls for Pharmacogenomic Testing |
| 08/06/2009 | US20090197899 3-(Dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide Derivatives and Methods of Use |
| 08/06/2009 | US20090197892 Anhydrous compositions useful for attaining enhanced sexual wellness |
| 08/06/2009 | US20090197883 Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods Of Use |
| 08/06/2009 | US20090197851 Therapy and use of compounds in therapy |
| 08/06/2009 | US20090197824 Extended Release Pharmaceutical Formulations of S-Adenosylmethionine |
| 08/06/2009 | US20090197820 Compositions and Methods for Improving Cardiovascular Health |
| 08/06/2009 | US20090197802 Analogues of GLP-1 |
| 08/06/2009 | US20090197337 Methods for the production of multimeric proteins and related compositions |
| 08/06/2009 | US20090196932 Pharmaceutical compositions of atorvastatin |
| 08/06/2009 | US20090196922 Bilayer tablet for preventing cardiovascular events |
| 08/06/2009 | US20090196876 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 08/06/2009 | US20090196865 Methods for the treatment and prevention of diseases of biological conduits |
| 08/06/2009 | US20090196862 High dosage Vitamin D |
| 08/06/2009 | DE102008007400A1 Substituierte Furane und ihre Verwendung Substituted furans and their use |
| 08/06/2009 | CA2713784A1 Use of amidoxime carboxylic acid esters and n-hydroxyguanidine carboxylic acid esters for producing prodrugs |
| 08/06/2009 | CA2712854A1 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 08/06/2009 | CA2712701A1 Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 08/05/2009 | EP2085780A2 Methods and products related to low molecular weight heparin |
| 08/05/2009 | EP2085402A1 Phosphates of secondary alcohols |
| 08/05/2009 | EP2085391A2 Inhibitors of factor XA and other serine proteases involved in the coagulation cascade |
| 08/05/2009 | EP2085389A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085388A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085387A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085094A2 Application of aminopeptidases inhibitors and pharmaceutical preparations containing same |
| 08/05/2009 | EP2085088A1 Adhesive preparation |
| 08/05/2009 | EP2085086A2 Method for treating congestive heart failure or diabetic nephropathy |
| 08/05/2009 | EP2085078A1 Controlled porosity osmotic pump tablet of high permeable drugs and the preparation method thereof |
| 08/05/2009 | EP2084151A1 Substituted dihydropyrazolones for treating cardiovascular and haematological diseases |
| 08/05/2009 | EP2084149A1 Organic compounds |
| 08/05/2009 | EP2084124A1 Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates |
| 08/05/2009 | EP2083834A2 Macrocyclic lactone compounds and methods for their use |
| 08/05/2009 | EP2083829A1 Use of phosphoenolpyruvate derivatives for treating necrosis of cardiac muscle tissue |
| 08/05/2009 | EP2083807A2 Use of a combination of hypothermia inducing drugs |
| 08/05/2009 | EP2083622A1 Omega-3 fatty acids for reduction of lp-pla2 levels |
| 08/05/2009 | EP1771178B1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies |
| 08/05/2009 | EP1581274B1 Injectable gel-forming compositions based on cross-linked and non-cross-linked polymers and the use thereof |
| 08/05/2009 | EP1560837B1 Novel ampiphilic derivatives of alpha-c-phenyl n-tert-butyl nitrone |
| 08/05/2009 | EP1509506B1 Pyridazine derivatives |
| 08/05/2009 | EP1503778B1 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
| 08/05/2009 | EP1465880B1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine |
| 08/05/2009 | EP1461313B1 Human adam-10 inhibitors |
| 08/05/2009 | EP1430040B1 Benzothiazepine derivatives |
| 08/05/2009 | EP1383731B1 Biaryl compounds as serine protease inhibitors |
| 08/05/2009 | EP1286662A4 Tablets and methods for modified release of hydrophilic and other active agents |
| 08/05/2009 | CN101501049A Aminophosphoric acid ester derivative and S1P receptor modulator containing the same as active ingredient |
| 08/05/2009 | CN101501020A Nitrate esters of piperidines |
| 08/05/2009 | CN101501007A Quinazoline derivative |
| 08/05/2009 | CN101500605A Therapeutic methods for treating vascular eye disorders with Dll4 antagonists |
| 08/05/2009 | CN101500563A Cycloalkanopyrolocarbazole derivatives and the use thereof as PARP, VEGFR2 and MLK3 inhibitors |